Stay updated on Pembrolizumab in mCRPC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in mCRPC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added a new frontend revision label: Revision: v3.5.0, and removed the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T17:41:54.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision label in the site footer updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:58:34.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The page shows a site revision: 'Revision: v3.4.2' is listed, with a prior entry for v3.4.1 and a legacy government funding notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:22:31.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added a site-wide funding notice and updated the page to revision v3.4.1, removing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T05:36:31.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Added a glossary toggle and a 'Last Update Submitted that Met QC Criteria' label; capitalization adjusted for 'No FEAR Act Data' and the site revision updated to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T03:50:08.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-14T01:13:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in mCRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.